671
Participants
Start Date
October 31, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
February 29, 2016
Dupilumab
Subcutaneous injection alternated among the different quadrants of the abdomen, upper thighs and upper arms
Placebo (for Dupilumab)
Subcutaneous injection alternated among the different quadrants of the abdomen, upper thighs and upper arms
Birmingham
Fort Smith
Rogers
Clovis
Lomita
Los Angeles
Oceanside
Palmdale
Rolling Hills Estates
San Diego
Santa Monica
Stockton
Boca Raton
Clearwater
Fort Lauderdale
Miami
Miami Lakes
Pensacola
Tampa
Newnan
Chicago
Normal
Evansville
Indianapolis
Louisville
Boston
Troy
St Louis
Newington
East Windsor
Buffalo
Corning
New Hyde Park
Rochester
High Point
Bethlehem
Upland
Chattanooga
Knoxville
San Antonio
Waco
Ogden
Newport News
Norfolk
Spokane
Dupnitsa
Plovdiv
Sofia
Winnepeg
Bathurst
Hamilton
Mississauga
Newmarket
Ottawa
Richmond Hill
Toronto
Copenhagen
Hellerup
Tallinn
Tartu
Helsinki
Tampere
Turku
Berlin
Bielefed
Blaubeuren Abbey
Erlangen
Halle
Hamburg
Hanover
München
Münster
Osnabrück
Schwerin
Stuttgart
Kurume
Fukuyama
Inashiki
Yokohama
Habikino
Neyagawa
Sakai
Takatsuki
Hamamatsu
Bunkyo-ku
Chuo-ku
Nerima-ku
Shinagawa
Shinjuku
Kofu
Gifu
Hiroshima
Kyoto
Osaka
Singapore
Alcañiz
Alicante
Barcelona
Madrid
Seville
Valencia
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY